• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cytokinetics Inc

+ Add to Watchlist

CYTK:US

3.8299 USD 0.1799 4.93%

As of 14:20:32 ET on 10/30/2014.

Snapshot for Cytokinetics Inc (CYTK)

Open: 3.6600 Day's Range: 3.5500 - 3.8500 Volume: 263,232
Previous Close: 3.6500 52wk Range: 3.0500 - 13.2600 1-Yr Rtn: -38.55%

Stock Chart for CYTK

No chart data available.
  • CYTK:US 3.8299
  • 1D
  • 1M
  • 1Y
3.6500
Interactive CYTK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYTK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7200
Est. EPS (USD) (12/2014) -1.0060
Est. PEG Ratio -
Market Cap (M USD) 137.65
Shares Outstanding (M) 36.61
30 Day Average Volume 288,900
Price/Book (mrq) 1.7863
Price/Sale (ttm) 2.6971
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYTK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CYTK

Cytokinetics, Incorporated is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

Robert I BlumPresident/CEOSharon A Barbari "Surrey"Exec VP:Finance/CFO/Secretary
Fady I MalikSenior VP:Research & Early DevAndrew A WolffSenior VP:Clinical Research
More Company Profile & Key Executives for CYTK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil